v3.26.1
Changes in Stockholders' Equity - Summary of Reconciliation of Changes in Stockholders Equity (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Equity    
Beginning balance $ 546,199 $ 126,589
Issuance of common stock upon exercise of stock options $ 51 327
Issuance of common stock upon exercise of stock options (in shares) 28,186  
Issuance of common stock upon exercise of common stock warrants $ 52 666
Vesting of Promote Sponsor Vesting Shares   32,946
Stock-based compensation 5,890 4,174
Foreign currency translation loss (391) (185)
Change in unrealized gain (loss) on available-for-sale securities (1,312) (8)
Net income 33,109 42,619
Ending balance 583,598 207,128
Common Stock    
Equity    
Beginning balance $ 33 $ 29
Beginning balance (in shares) 331,283,000 283,547,000
Issuance of common stock upon exercise of stock options (in shares) 28,000 298,000
Issuance of common stock upon exercise of common stock warrants (in shares) 3,000 46,000
Issuance of common stock upon release of restricted stock units ("RSUs") (in shares) 994,000 3,084,000
Ending balance $ 33 $ 29
Ending balance (in shares) 332,308,000 286,975,000
Additional Paid-In Capital    
Equity    
Beginning balance $ 1,316,126 $ 681,202
Issuance of common stock upon exercise of stock options 51 327
Issuance of common stock upon exercise of common stock warrants 52 666
Vesting of Promote Sponsor Vesting Shares   32,946
Stock-based compensation 5,890 4,174
Ending balance 1,322,119 719,315
Accumulated Other Comprehensive Income (Loss)    
Equity    
Beginning balance 997 105
Foreign currency translation loss (391) (185)
Change in unrealized gain (loss) on available-for-sale securities (1,312) (8)
Ending balance (706) (88)
Accumulated Deficit    
Equity    
Beginning balance (770,957) (554,747)
Net income 33,109 42,619
Ending balance $ (737,848) $ (512,128)